Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Application of 0.02% MMC over 60 seconds post corneal crosslinking.
Total 1 results
Ciusss de L'Est de l'Île de Montréal
Terminated
The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus Patients
Keratoconus
Canada
Sponsors and Collaborators
Health Factors Inc
University Mental Health Research Institute, Athens, Greece
National Institute of Diabetes and Endocrinology, Egypt
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Genesis Foundation
Manresana de Micobacteriologia, SL
Julie Lefevere
Stanford's Innovative Medicines Accelerator
Rotem Petranker
Michael Scharl
Azumio Inc.
Ondine Biomedical Inc.
Montera Health Texas LLC
Spokane Regional Health District
National Institute of Drug Abuse
Ancon Technologies Ltd
AVAX Technologies
Robert Pendleton
Prostate Cure Foundation
Daqiao Community Health Service Center of Yangpu District
View Full List
Medical Conditions
Intramural Haematoma of Thoracic Aorta
Maxillary Deficiency
Spondylitis Secondary to Inflammatory Bowel Disease
To Analyze the Frequency of Posttraumatic Stress Disorder in Cases With Awareness and Possible Awareness
Five-year Survival Rate
Stimulant Use (Diagnosis)
Acute Myocardial Infraction or Chest Pain
Focal Cortical Dysplasia
Disorder of Nipple
Germinal Center B-cell Type (GCB)
Periprosthetic Fracture of the Upper or Lower Limb
FIGO Stage III Primary Peritoneal Cancer
Heart Failure With Reduced Ejection Fraction (HFrEF)
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Lack of Drug Action
Severe Haemophilia A
Associated Conditions
Tumor, Benign
Benign Lymphoproliferative Disorder
Attention Deficit Hyperactivity Disorder Symptoms
View Full List
Drug Interventions
Treament C
Mild sedation and analgesia
Single dose of vepdegestrant as tablet formulation (Treatment A)
DKN-01
Ciclesonide
Nab-paclitaxel
Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
Uprifosbuvir
PD-0332991
GM-CSF
JNJ 10229570-AAA 3.6% cream
Colchicine group (experimental arm)
Golcadomide
Bevacizumab
Administration of etoricoxib
Glycopyrrolate
Megestrol Acetate 160 MG
Human menopausal gonadotropin
Formulation N3
G-CSF
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Australia
Contract Research Organizations in Bulgaria
Contract Research Organizations in Chile
Contract Research Organizations in Ecuador
Contract Research Organizations in Israel
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Mauritania
Contract Research Organizations in Moldova
Contract Research Organizations in Singapore
Contract Research Organizations in Slovenia
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Bulgaria
BiTrial Clinical Research
SanaClis
GCT (Global Clinical Trials)
ROSENBAUM GROUP
ACROSS Global
OCT Clinical
Comac Medical
SGS
Dokumeds
Institute for Medical Research (IMR)
All CROs in Bulgaria
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe